SSAO inhibitor-2

Overview

SSAO inhibitor-2 is a selective semicarbazide-sensitive amine oxidase ( SSAO/VAP-1 ) inhibitor with an IC 50 of < 10 nM. SSAO inhibitor-2 can be used for the research of inflammation diseases, diabetes and diabetes-related diseases, mental disorders, pain-related diseases, ischemic diseases, vascular diseases, ocular diseases, fibrosis, neuroinflammatory diseases, cancer , and tissue transplant rejection.

Application

Products | Products > Disease Areas > Pain | Products > Disease Areas > Type 1 Diabetes | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > VAP-1

Product Information

• Catalog No.: HY-143721
• CAS No.: 2671028-06-9
• Molecular Formula: C14H21FN4O2
• Molecular Weight: 296.34
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source